hsa-and-interpol-are-jointly-working-to-curb-the-menace-of-cyber-pharmaceutical-crimes-and-counterfeit-drugs-in-singapore

Interpol, HSA seized $14,548 fake drugs in 2012

  • Singapore
  • |
  • Regulatory
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Singapore: Asia Regulatory Conference 2013, the three-day event that has been organized by Health Sciences Authority (HSA), Drug Information Association (DIA) and... Read more

singapore-s-health-sciences-authority-hsa-and-netherlands-medicines-evaluation-board-meb-sign-memorandum-of-understanding-mou

Singapore, Dutch regulators sign health MoU

  • Singapore
  • |
  • Regulatory
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Singapore: Health Sciences Authority's (HSA) Asia Regulatory Conference 2013 saw Singapore and Dutch regulators sign a memorandum of understanding (MoU) to collaboratively... Read more

lipidomics-research-is-being-exhaustively-explored-in-singapore

Singapore takes a lipidomics leap

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

After proteomics and genomics, lipidomics promises to be the next emerging field of research in the bioscience industry. Its potential use in healthcare, including... Read more

dr-colin-wilde-and-dr-lee-hong-boon

AseaCyte predicts cell behaviour for future therapies

  • Malaysia
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Malaysia-based AseaCyte is emerging as an instrumental firm in the domain of human disease analysis, through its cell culture technology and cell-based analysis... Read more

bioscience-industry-trends-2013

What bioscience trends do the industry leaders predict for...

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 1 Comment

The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends that were so far just talk in the laboratories.... Read more

ms-lim-bee-koong-director-healthcare-strategy-ups-asia-pacific-singapore

UPS APAC director: Temperature sensitive shipment demand...

  • Singapore
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Delivering pharmaceutical products to the designated market at right time and in right condition is the most critical task that any pharmaceutical company aims to... Read more

mr-leonard-ariff-bin-abdul-shatar-president-malaysian-organisation-of-pharmaceutical-industries-mopi

Malaysia is ideal for pharma manufacturers

  • Malaysia
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Mr Leonard Ariff bin Abdul Shatar forayed into the pharmaceutical industry of Malaysia in late 90s and since then he gained wide experience and credibility in the... Read more

logistics-are-the-backbone-of-pharma-and-biotech-infrastructure-and-need-to-be-efficient

Logistics demand attention as outsourcing picks up

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

The European Medical Agency (EMA) recently raised concerns that since many sources of active substances for life-saving medicines are now wholly located outside... Read more

mr-herbert-vongpusanachai-managing-director-dhl-express-singapore

DHL MD: Poor logistics hinder drug shipments

  • Singapore
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Mr Herbert Vongpusanachai has spent almost a decade managing Asian logistics market through DHL and has earned in-depth experience of the trends in Singapore, Cambodia,... Read more

point-of-care-diagnostics-ushering-in-a-paradigm-shift-in-healthcare

Point-of-care diagnostics is revolutionary

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

In 2011, the Bill & Melinda Gates Foundation rolled out a new grant of $31 million to fund innovation in point-of-care diagnostics (POCD) in the developing world.... Read more

technologies-like-the-one-used-on-the-veredus-veremtb-image-lab-on-chip-device-are-revolutionizing-the-diagnostic-industry

Lab-on-chips usher in an era of shrinking labs

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Gone would be the days when patients will have to walk-in to their pathologists for diagnosis of a disease and wait for several weeks to get the result for tests... Read more

mr-yab-tan-sri-muhyiddin-yassin-second-from-right-deputy-prime-minister-malaysia-during-the-launch-of-biomalaysia-2012

BioMalaysia 2012 focuses on the nation's bio-economy

  • Malaysia
  • |
  • News
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Kuala Lumpur: Malaysia is looking at strategies to increase bio-scalability and increase competitiveness in the country and in a bid to do so, it is looking at undertaking... Read more

dr-kaveh-safavi-md-north-america-health-accenture

Accenture MD: Only highly evolved nations spend on IT healthcare...

  • Singapore
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Integration of information and technology (IT) in healthcare services and translating the potential into better delivery is a trend being witnessed across the world.... Read more

datuk-dr-mohd-nazlee-kamal-ceo-malaysian-biotechnology-corporation-biotechcorp

Nazlee Kamal: Malaysia is a collaboration hub

  • Malaysia
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Dato' Dr Mohd Nazlee Kamal, is the chief executive officer (CEO) of the Malaysian Biotechnology Corp (BiotechCorp), which is the lead development agency for the... Read more

mr-simranjit-singh-chairman-biosingapore

Local biomedical firms face hurdles in Singapore

  • Singapore
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Biomedical association of Singapore, BioSingapore, recently appointed Mr Simranjit Singh, director, strategic planning Asia, Quintiles, as its new chairman. In an... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X